EQA PROGRAMME CATALOGUE - 77 Pages

Add to MyMedicalExpo favorites
EQA PROGRAMME CATALOGUE

Catalog excerpts

An Introduction to the QCMD EQA Schemes    5 Blood Borne Virus    6 Central Nervous System    6 Immunocompromised Associated Diseases    9 Sexually Transmitted Infections    11 Transplant Associated Diseases    11 Cytomegalovirus Dried Blood Spots    16 Cytomegalovirus Whole Blood    16 Epstein-Barr virus Whole Blood    19 Herpes simplex virus 1& 2    25 Herpes simplex virus Drug Resistance    25 HIV-1 Drug Resistance (Integrase)    27 Human herpes virus 6    28

 Open the catalog to page 2

Human Papillomavirus (PreservCyt)    29 Influenza Haemagglutinin Typing    30 Respiratory syncytial virus    34 West Nile virus    35 Borrelia burgdorferi spp. (Lyme Disease)    38 Chlamydia trachomatis and Neisseria gonorrhoeae    39 Diarrheagenic Escherichia coli    41 Extended Spectrum ^-lactamase and Carbapenemase    41 Methicillin Resistant Staphylococcus aureus    43 Methicillin Resistant Staphylococcus aureus Typing    44 (epidemiology and outbreak studies) Mycobacterium tuberculosis    44 Mycoplasma spp. (cell contamination)    45 Vancomycin Resistant Enterococci    47 Pneumocystis...

 Open the catalog to page 3

Contents Multiple Pathogen EQA Bacterial Gastroenteritis MALDI-TOF Parasitic Gastroenteritis Respiratory I Respiratory II Respiratory III Sexually Transmitted Infections I Sexually Transmitted Infections II Viral Gastroenteritis EQA Pilot Studies CNSI (Viral) CNSII (Non-viral) Human Papillomavirus (Surepath) Immunocompromised Mycoplasma genitalium Neonatal / Newborn infections Sepsis Torque teno virus Transplantation (viral) Trichomonas vaginalis New Molecular EQA Pilot Studies for 2019 Arthropod-borne viruses Atypical mycobacterium Mycobacterium tuberculosis Drug Resistance Yellow fever...

 Open the catalog to page 4

An Introduction to the QCMD EQA Schemes The aim of QCMD's External Quality Assessment (EQA) programmes are to help monitor and improve laboratory quality by assessing a laboratory's use of molecular diagnostic technologies within the routine clinical setting. The EQA schemes are both educational and regulatory in application and support continuous quality improvement, as well as assist laboratory accreditation / certification to ISO15189 or equivalent. Who can participate? The QCMD EQA programmes are open to any clinical laboratory conducting molecular based tests for the routine diagnosis...

 Open the catalog to page 5

EQA GroupsBloodborne Virus The Bloodborne Virus (BBV) group of QCMD External Quality Assessment (EQA) programmes consists of pathogens that are classically detected directly from the blood. This includes human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) B19 virus (B19) and more recently hepatitis A virus (HAV), hepatitis E virus (HEV) and hepatitis D virus (HDV). To compliment the detection and viral load determination programme above a range of genotyping and drug resistance BBV EQA programmes are available. For the drug resistance BBV EQA programmes...

 Open the catalog to page 6

EQA Groups Congenital Infections The term congenital infection is used to describe those infections transmitted from mother to child either during pregnancy (Transplacental infection) or immediately after childbirth. They can be caused by viruses, bacteria and on occasion parasites. The ability of a particular pathogen to cross the placenta and infect the foetus /embryo is dependent on many factors including the mother’s immune status. Primary infections during pregnancy can result in spontaneous abortion or major developmental disorders if undetected and left untreated. Cytomegalovirus...

 Open the catalog to page 7

EQA Groups Exotic/Emerging Diseases A complex relationship exists between pathogen genetics, host and the environment. As a result, predicting the future emergence of exotic diseases is difficult. However, globalisation coupled with rapid increases in human populations over the last 50 years has played an important role. Local environmental changes such as deforestation due to urbanisation bring humans into closer contact with potential new pathogen vectors. These factors disturb the subtle balance between pathogen, host and the environment and create the opportunity for the emergence of...

 Open the catalog to page 8

Immunocompromised Associated Diseases The treatment and management of patients with compromised immune systems has seen important developments in recent years with, for example, the introduction of novel multi-drug treatment regimes. As a result, the healthcare and management of immunocompromised patients has greatly improved. However, pathogen infection or viral reactivation remain significant contributors to morbidity and mortality in these patients. A number of opportunistic parasitic, fungal and viral pathogens are of concern in the management of immunocompromised patients due to both...

 Open the catalog to page 9

Respiratory Diseases Respiratory tract infections (RTIs) are common conditions, experienced by most adults and children each year. They can affect both the upper and lower respiratory tract and range from the common cold to viral and bacterial pneumonia. For the young, the elderly and the immune compromised, RTIs can be a significant health threat if not managed effectively. RTIs can be caused by a large number of bacterial, viral and fungal pathogens which have nearly indistinguishable physiological symptoms. This can increase the chances of undiagnosed or misdiagnosed infections leading...

 Open the catalog to page 10

Sexually transmitted infections (STIs) remain a major public health concern throughout the world with some infections reaching epidemic proportions in sexually active groups. As a result, a number of WHO and UN global strategies have been initiated in an attempt to control the spread of STIs. STIs are the main preventable cause of infertility, particularly in women. However, some STIs remain asymptomatic before leading to serious reproductive complications and congenital infections, therefore appropriate diagnosis and treatment is essential. Molecular diagnostic assays allow the accurate...

 Open the catalog to page 11

All AB Analitica catalogs and technical brochures

  1. HP UREASI TEST

    2 Pages